Results 11 to 20 of about 159,303 (377)

Subunit vaccines for Acinetobacter baumannii

Frontiers in Immunology, 2023
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen in hospitals. A. baumannii infection has become a challenging problem in clinical practice due to the increasing number of multidrug-resistant strains and their ...
N. Yang, Xiaomeng Jin, Chen-Ye Zhu, Fengling Gao, Zheqi Weng, Xingran Du, Ganzhu Feng   +6 more
semanticscholar   +4 more sources

Tackling Acinetobacter baumannii

Journal of Clinical Medicine, 2023
Globally, multidrug-resistant (MDR) bacteria represent a menace to public health [...].
G. Granata, F. Taglietti, N. Petrosillo
semanticscholar   +3 more sources

Acinetobacter baumannii: an evolving and cunning opponent

Frontiers in Microbiology
Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is increasing because of several factors, including unregulated antibiotic use. A.
Jingchao Shi, Jianghao Cheng, Shourong Liu, Yufeng Zhu, Mingli Zhu   +4 more
semanticscholar   +4 more sources

Acinetobacter baumannii [PDF]

Trends in Microbiology, 2022
Acinetobacter baumannii is a ubiquitous, Gram-negative, nonflagellated coccobacillus bacterium commonly isolated from the environment. In human medicine, this opportunistic pathogen is responsible for hospital- and community-acquired infections. Resistance to last-resort antibiotics, such as colistin, tigecycline, and carbapenems, earns this bacterium ...
Clémence Whiteway, Anke Breine, Chantal Philippe, Charles Van der Henst   +3 more
openaire   +5 more sources

A review on Acinetobacter baumannii

Journal of Acute Disease, 2019
Acinetobacter baumannii is a major cause of nosocomial infections worldwide. By summarizing the epidemiology, molecular and drug resistance mechanisms, diagnosis and treatment strategies of Acinetobacter baumannii, the clinical outcome is finally ...
Xin Wang, Li-Jie Qin
doaj   +2 more sources

Acinetobacter baumannii [PDF]

Virulence, 2012
Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospital-acquired infections. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrug-resistant (MDR) strains, has significantly raised the ...
Howard, Aoife, O’Donoghue, Michael, Feeney, Audrey, Sleator, Roy D.   +3 more
openaire   +3 more sources

Resistance mechanisms of tigecycline in Acinetobacter baumannii

Frontiers in Cellular and Infection Microbiology, 2023
Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a common pathogen causing various infectious diseases. Currently, the drug resistance rate of A.
Chunli Sun, Yunsong Yu, X. Hua
semanticscholar   +1 more source

Uncovering the mechanisms of Acinetobacter baumannii virulence

Nature Reviews Microbiology, 2017
Christian M Harding, Mario F Feldman
exaly   +2 more sources

Drug‑resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics (Review)

Experimental and Therapeutic Medicine, 2023
Bacterial drug resistance is increasingly becoming an important problem that needs to be solved urgently in modern clinical practices. Infection caused by Acinetobacter baumannii is a serious threat to the life and health of patients. The drug resistance
Hao Wu, Z. Xiao, Xiaojuan Lv, Hai-Tang Huang, Chu Liao, Chen Hui, Yue Xu, Hengran Li   +7 more
semanticscholar   +1 more source

Acinetobacter baumannii Antibiotic Resistance Mechanisms

Pathogens, 2021
Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates.
I. Kyriakidis, E. Vasileiou, Z. Pana, A. Tragiannidis   +3 more
semanticscholar   +1 more source